Pharmafile Logo
Pharmafocus logo
Advanced Search

Cambodian bat researchers aiming to find COVID-19 origin

September 20, 2021
Research and Development, Sales and Marketing

An eight-member Institut Pasteur du Cambodge (IPC) research team has been collecting samples from bats in an attempt to discover …

News

ONS data shows long COVID less common than feared

September 17, 2021
Medical Communications

New data released by the Office for National Statistics (ONS) reveal that only one in 40 people with coronavirus goes …

News

NICE recommends MSD’s Keytruda for oesophageal cancer patients

September 17, 2021
Medical Communications, Research and Development

NICE has approved the use of pembrolizumab – MSD’s checkpoint inhibitor immunotherapy – in combination with platinum- and fluoropyrimidine-based chemotherapy, …

News

Health Canada announce first full approval for Moderna COVID-19 vaccine

September 17, 2021
Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …

News
moderna_norwood_plant

Moderna and Pfizer COVID-19 vaccine protection declines over time

September 16, 2021
Business Services COVID-19, FDA, Moderna, Pfizer, comirnaty

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …

News

Researchers develop AI algorithm to diagnose deep vein thrombosis

September 16, 2021
Medical Communications, Research and Development

Researchers from the University of Oxford, Imperial College, and the University of Sheffield have developed a machine learning algorithm with …

News

Menstrual changes after COVID jab must be investigated, says leading immunologist

September 16, 2021
Medical Communications

Changes to periods and unexpected vaginal bleeding has been reported by 30,000 women to UK regulators, and now leading immunologist …

News

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021
Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …

News

COVID deaths among fully vaccinated rare, ONS data finds

September 15, 2021
Medical Communications, Research and Development

New figures from the Office for National Statistics (ONS) show that fully vaccinated people are far less likely to die …

News

Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA

September 15, 2021
Manufacturing and Production, Medical Communications, Research and Development

On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …

News
nhs_sign

NHS in Scotland makes rheumatoid arthritis drug available

September 14, 2021
Manufacturing and Production Galapagos UK, NHS, Scotland, filgotinib, rheumatoid arthritis

The Scottish Medicines Consortium (SMC) have recommended the use of Galapagos UK’s JYSELECA® (filgotinib) for eligible patients with severe active …

News

Israeli survey finds 1 in 10 children have long COVID

September 14, 2021
Medical Communications, Research and Development

An Israeli Health Ministry survey has found that one in ten children have lingering COVID-19 symptoms after contracting and recovering …

News

J&J publish promising Ebola vaccine data

September 14, 2021
Research and Development

Johnson & Johnson have released promising data regarding their Ebola vaccine regimen, as it demonstrates antibody immune responses in adults …

News

NHS launches new blood test to detect over 50 types of cancer early

September 13, 2021
Sales and Marketing

A world-first trial of a new cancer test began today as the NHS launched its Galleri trial, which seeks to …

News
dw-anzcxqaqavhl

BioNTech seek approval for COVID-19 vaccine in children aged 5-11

September 13, 2021
Sales and Marketing COVID-19, FDA, Vaccine, children

Children between 5 and 11 years old are to be targeted by BioNTech as the company seeks approval for younger …

News
valneva-05

Valneva COVID-19 vaccine deal pulled by UK government

September 13, 2021
Research and Development, Sales and Marketing Boris Johnson, Scotland, UK government, Vaccine, Valneva, booster, covid19

Boris Johnson and the UK government have terminated its deal with specialist vaccine company Valneva after it was alleged the …

News

NICE recommends Pfizer’s Xeljanz for juvenile idiopathic arthritis

September 10, 2021
Medical Communications

NICE has published final draft guidance recommending the use of Pfizer’s Xeljanz (tofacitinib) as an option for treating active polyarticular …

News

Pfizer and AstraZeneca approved as booster COVID vaccines

September 10, 2021
Medical Communications

The MHRA has approved the use of Pfizer and AstraZeneca’s COVID-19 vaccines for the planned booster programme this winter. However, …

News
nhs_old_hospital_1

NHS lung cancer patients to receive Amgen’s tumour-stopping drug

September 10, 2021
Medical Communications, Research and Development

NHS patients will be the first in Europe to receive a new drug that can prevent lung cancer tumour growth, …

News

FDA grants Fast Track Designation for Vor Biopharma’s AML drug

September 10, 2021
Medical Communications, Research and Development

Vor Biopharma has announced that the FDA has granted their acute myeloid leukemia (AML) engineered hematopoietic stem cell therapy (eHSC), …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026